- Home
- ARQT vs MGEE Comparison
ARQT vs MGEE Comparison
Compare ARQT & MGEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | MGEE |
|---|---|---|
| Founded | 2016 | 1855 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2020 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ARQT | MGEE |
|---|---|---|
| Price | $20.44 | $75.68 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 2 |
| Target Price | $34.00 | ★ $80.50 |
| AVG Volume (30 Days) | ★ 1.8M | 283.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.41% |
| EPS Growth | ★ 88.79 | 11.71 |
| EPS | N/A | ★ 1.32 |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | $4.02 |
| Revenue Next Year | $29.39 | $2.77 |
| P/E Ratio | ★ N/A | $57.26 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.72 | $72.17 |
| 52 Week High | $31.77 | $91.46 |
Technical Indicators
Market Signals| Indicator | ARQT | MGEE |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 43.71 |
| Support Level | $19.60 | $72.59 |
| Resistance Level | $24.56 | $82.48 |
| Average True Range (ATR) | 1.27 | 1.68 |
| MACD | -0.20 | -0.25 |
| Stochastic Oscillator | 23.32 | 30.61 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About MGEE MGE Energy Inc
MGE Energy provides electric service to 170,000 customers and natural gas service to 180,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.